Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)Wei Yang,Sujun Gao,Xiaojing Yan,Rong Guo,Lijie Han,Fei Li,Yafei Wang,Junmin Li,Chunkang Chang,Haiping Yang,Ronghua Hu,Hongyan Tong,Xingli Zhao,Qiubai Li,Jingdong Zhang,Xin Du,Sanfang Tu,Cheng Zhang,Congmeng Lin,Xin DuBlood(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要